(PTHS)
ASE – Real vaqt narxi. Valyuta: USD
22.49
-0.25 (-1.10%)
Yopilishda: Mar 27, 2026, 11:07 AM EDT
22.49
0.00 (0.00%)
Bozordan keyin: Mar 27, 2026, 6:22 PM EDT

ASE – Real vaqt narxi. Valyuta: USD
22.49
-0.25 (-1.10%)
Yopilishda: Mar 27, 2026, 11:07 AM EDT
22.49
0.00 (0.00%)
Bozordan keyin: Mar 27, 2026, 6:22 PM EDT
Pelthos Therapeutics Inc., biofarmatsevtika kompaniyasi, davolashda qondirilmagan ehtiyojlarga ega bo'lgan bemorlarga yordam berish uchun terapevtik mahsulotlarni ishlab chiqadi va tijoratlashtiradi. Kompaniya kattalar va 1 yosh va undan katta bolalarda molluskum kontagiozumni davolash uchun ZELSUVMI; Staphylococcus aureus yoki Streptococcus pyogenes tomonidan qo'zg'atilgan impetigoni kattalar va 2 oylik va undan katta bolalarda davolash uchun xinolon antimikrob vositasi bo'lgan XEPI, (ozenoxacin) kremini; va 6 oylik va undan katta bemorlarda bosh bitlarining yuqishini mahalliy davolash uchun ko'rsatilgan pedikulitsid XEGLYZEni taklif etadi. Kompaniya shuningdek, azot oksidi asosidagi patentlangan texnologiya platformasi NITRICILni taqdim etadi. Kompaniya avval Channel Therapeutics Corporation nomi bilan tanilgan bo'lib, 2025 yil iyul oyida Pelthos Therapeutics Inc. nomini o'zgartirgan. Pelthos Therapeutics Inc. 2002 yilda tashkil etilgan va Shimoliy Karolina shtatining Durham shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Mr. Francis Knuettel II, M.B.A. | CFO, Secretary & Treasurer |
| Mr. Scott M. Plesha | CEO, President & Director |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-03-19 | 8-K | pths-20260319.htm |
| 2026-02-02 | S-3 | g085075_s3.htm |
| 2026-01-13 | 8-K | g085079_8k.htm |
| 2026-01-12 | 8-K | g085077_8k.htm |
| 2026-01-02 | 8-K | g085066_8k.htm |
| 2025-12-23 | 8-K | g085052_8k.htm |
| 2025-12-17 | 8-K | g085048_8k.htm |
| 2025-12-01 | ARS | g085031_ars.pdf |
| 2025-11-25 | DEF 14A | g085027_def14a.htm |
| 2025-11-19 | D |